These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20201020)

  • 1. The controversial relationship between NLRP3, alum, danger signals and the next-generation adjuvants.
    Spreafico R; Ricciardi-Castagnoli P; Mortellaro A
    Eur J Immunol; 2010 Mar; 40(3):638-42. PubMed ID: 20201020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of inflammasomes in the immunostimulatory effects of particulate vaccine adjuvants.
    Harris J; Sharp FA; Lavelle EC
    Eur J Immunol; 2010 Mar; 40(3):634-8. PubMed ID: 20201019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of action of licensed vaccine adjuvants.
    Tritto E; Mosca F; De Gregorio E
    Vaccine; 2009 May; 27(25-26):3331-4. PubMed ID: 19200813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of adaptive immunity by the NLRP3 inflammasome.
    Chen M; Wang H; Chen W; Meng G
    Int Immunopharmacol; 2011 May; 11(5):549-54. PubMed ID: 21118671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants.
    Eisenbarth SC; Colegio OR; O'Connor W; Sutterwala FS; Flavell RA
    Nature; 2008 Jun; 453(7198):1122-6. PubMed ID: 18496530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the NLRP3 inflammasome is not a feature of all particulate vaccine adjuvants.
    Neumann S; Burkert K; Kemp R; Rades T; Rod Dunbar P; Hook S
    Immunol Cell Biol; 2014 Jul; 92(6):535-42. PubMed ID: 24687021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alum adjuvanticity: unraveling a century old mystery.
    De Gregorio E; Tritto E; Rappuoli R
    Eur J Immunol; 2008 Aug; 38(8):2068-71. PubMed ID: 18651701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulatory properties of the vaccine adjuvant alum.
    Oleszycka E; Lavelle EC
    Curr Opin Immunol; 2014 Jun; 28():1-5. PubMed ID: 24463269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunology of TLR-independent vaccine adjuvants.
    De Gregorio E; D'Oro U; Wack A
    Curr Opin Immunol; 2009 Jun; 21(3):339-45. PubMed ID: 19493664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3.
    Li H; Willingham SB; Ting JP; Re F
    J Immunol; 2008 Jul; 181(1):17-21. PubMed ID: 18566365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of action of clinically approved adjuvants.
    Lambrecht BN; Kool M; Willart MA; Hammad H
    Curr Opin Immunol; 2009 Feb; 21(1):23-9. PubMed ID: 19246182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alum: an old dog with new tricks.
    Wen Y; Shi Y
    Emerg Microbes Infect; 2016 Mar; 5(3):e25. PubMed ID: 27004761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-4- and NACHT, LRR and PYD domains-containing protein 3-independent mechanisms of alum enhanced T helper type 2 responses on basophils.
    Huang FJ; Ma YL; Tang RY; Gong WC; Li J; Chen CX; Yin L; Chen XP
    Immunology; 2016 Oct; 149(2):238-51. PubMed ID: 27315109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutting edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome.
    Kool M; Pétrilli V; De Smedt T; Rolaz A; Hammad H; van Nimwegen M; Bergen IM; Castillo R; Lambrecht BN; Tschopp J
    J Immunol; 2008 Sep; 181(6):3755-9. PubMed ID: 18768827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Illuminating alum.
    Schubert C
    Nat Med; 2009 Sep; 15(9):985. PubMed ID: 19734863
    [No Abstract]   [Full Text] [Related]  

  • 16. NLRP3 inflammasome activation and cytotoxicity induced by particulate adjuvants.
    Yang M; Hearnden CH; Oleszycka E; Lavelle EC
    Methods Mol Biol; 2013; 1040():41-63. PubMed ID: 23852596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sterile inflammatory responses mediated by the NLRP3 inflammasome.
    Cassel SL; Sutterwala FS
    Eur J Immunol; 2010 Mar; 40(3):607-11. PubMed ID: 20201012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvanticity of the oil-in-water emulsion MF59 is independent of Nlrp3 inflammasome but requires the adaptor protein MyD88.
    Seubert A; Calabro S; Santini L; Galli B; Genovese A; Valentini S; Aprea S; Colaprico A; D'Oro U; Giuliani MM; Pallaoro M; Pizza M; O'Hagan DT; Wack A; Rappuoli R; De Gregorio E
    Proc Natl Acad Sci U S A; 2011 Jul; 108(27):11169-74. PubMed ID: 21690334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alum induces innate immune responses through macrophage and mast cell sensors, but these sensors are not required for alum to act as an adjuvant for specific immunity.
    McKee AS; Munks MW; MacLeod MK; Fleenor CJ; Van Rooijen N; Kappler JW; Marrack P
    J Immunol; 2009 Oct; 183(7):4403-14. PubMed ID: 19734227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signaling by ROS drives inflammasome activation.
    Martinon F
    Eur J Immunol; 2010 Mar; 40(3):616-9. PubMed ID: 20201014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.